Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2003
10/30/2003US20030203902 A 2-hydroxy-2-trifluoromethyl-valeroylamino benzotriazole, or benzo(1,2,5)thiadiazole, or benzo(1,2,5)oxadiazole derivatives; contraceptive agents, for treating endometriosis, gynecological disorders, male birth control
10/30/2003US20030203901 Methods of modulating tyrosine protein kinase function with indolinone compounds
10/30/2003US20030203900 An inhibitors against Cathepsin enzyme, 4-oxo-tetrahydrofuran-3s-ylcarbamoyl derivatives, for treating degenerative diseases
10/30/2003US20030203895 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
10/30/2003US20030203872 Such as 1-(4-thio-beta-D-arabinofuranosyl)cytosine for treatment of cancer; gene expression inhibition
10/30/2003US20030201713 Design and synthesis of advanced NLO materials for electro-optic applications
10/30/2003CA2488929A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355903A1 Pyrazole derivatives against tgf overexpression
10/29/2003EP1355900A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355889A1 Substituted triazole diamine derivatives as kinase inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1149092B1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/29/2003EP1112256B1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
10/29/2003EP1091952B1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1012166B1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
10/29/2003EP0976735B1 Process for producing piperidinecarboxylic acid amides
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/29/2003CN1125821C Compounds derived from thophene and benzothiophene, and related utilisation and compsn.
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6638973 Taxane formulations
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638960 Use as microbicides, especially fungicides, in crop protection
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2104268C Preparation of imidazoles
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087094A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087064A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
10/23/2003WO2003087063A1 Imidazolidine compounds as chemokine receptor modulators
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086388A1 Estrogen receptor modulators
10/23/2003WO2003086385A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002042272A8 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030199692 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
10/23/2003US20030199691 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003US20030199689 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
10/23/2003US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management
10/23/2003US20030199547 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent
10/23/2003US20030199530 New compounds derived from quinazoline
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199516 Methods of treating infection by drug resistant bacteria
10/23/2003US20030199511 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine
10/23/2003US20030199506 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease
10/23/2003US20030199505 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199504 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199473 For therapy of retrovirus infection
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2482544A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003CA2482536A1 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353902A2 Inhibitors of serine protease activity of matriptase or mtsp1
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1007523B1 Indole and 2,3-dihydroindole derivatives, their preparation and use
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451002A Indole derivatives for treating central nervous system disease
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125065C Benzo[g] quinoline derivatives
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 523